Evelyne Dietrich

发表

Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis.

G. Moeck, F. Arhin, Stephane Ciblat, 2010, Bioorganic & medicinal chemistry letters.

Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.

Hugo Poirier, D. Delorme, Jing Liu, 2008, Bioorganic & medicinal chemistry.

Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.

Hugo Poirier, D. Delorme, Jing Liu, 2008, Journal of medicinal chemistry.

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

Stephen J. Morris, D. Durocher, R. Stocco, 2022, Nature.

Vancomycin and oritavancin have different modes of action in Enterococcus faecium.

G. Patti, J. Schaefer, S. Kim, 2009, Journal of molecular biology.

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition

D. Durocher, R. Stocco, A. Roulston, 2021, Nature.

Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus.

J. Schaefer, S. Kim, Kelly S. E. Tanaka, 2013, Biochemistry.

Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC.

Hugo Poirier, D. Delorme, G. McKay, 2006, Bioorganic & medicinal chemistry letters.

Efficient synthesis of enantiopure pyrrolizidinone amino acid.

W. Lubell, Evelyne Dietrich, 2003, The Journal of organic chemistry.

Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus.

L. Cegelski, Manmilan Singh, J. Schaefer, 2008, Journal of molecular biology.

Novel Non‐Nucleobase Inhibitors of Staphylococcus aureus DNA Polymerase IIIC.

Hugo Poirier, D. Delorme, G. McKay, 2006 .

Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic cores.

L. Chan, S. Das, Oswy Z. Pereira, 2015, Bioorganic & medicinal chemistry letters.

Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306.

R. Stocco, F. Sicheri, P. Beaulieu, 2022, Journal of medicinal chemistry.

A new class of small molecule RNA polymerase inhibitors with activity against rifampicin-resistant Staphylococcus aureus.

J. Pelletier, P. Gros, D. Delorme, 2006, Bioorganic & medicinal chemistry.

Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1b.

L. Chan, S. Das, L. L'Heureux, 2015, Bioorganic & medicinal chemistry letters.

Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkers.

L. Chan, S. Das, L. L'Heureux, 2015, Bioorganic & medicinal chemistry letters.

Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis

G. Moeck, F. Arhin, D. Lehoux, 2008, ChemMedChem.

Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potency.

L. Chan, S. Das, Oswy Z. Pereira, 2015, Bioorganic & medicinal chemistry letters.